Summary Summary Short summary of a recent publication, written by scientific experts. Published: 28 Oct 2018

Rapid detection of genetic mutations in diffuse glioma

Takeaway

  • GliomaDx assays can detect TERTp/IDH mutations, are 200 times more sensitive and have quicker turnaround times in comparison to Sanger sequencing.

Why this matters

  • Current diagnostic tests for diffuse glioma lack sensitivity and have long turnaround times.